Evidence map›Paper›PMID 40568936›Full record

ArticleNucleic acids research2025

Identification of a minimal Alu domain required for retrotransposition.

John B Moldovan, John Yin, John V Moran

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

John B MoldovanDepartment of Human Genetics, University of Michigan Medical School, Ann Arbor, MI 48109, United States.ORCID 0000-0002-1703-734X
John YinDepartment of Human Genetics, University of Michigan Medical School, Ann Arbor, MI 48109, United States.
John V MoranDepartment of Human Genetics, University of Michigan Medical School, Ann Arbor, MI 48109, United States.ORCID 0000-0002-5308-4864

Funding

Gen. &Mol. Analysis of Human LINE-1 RetrotranspositionR01GM060518 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MORAN, JOHN V. · 1999 to 2024
$4.8M
Identification of Factors Critical for SINE RetrotranspositionR01GM140135 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KIDD, JEFFREY M, MORAN, JOHN V. · 2021 to 2024
$1.9M
NIGMS NIH HHS GM060518NIGMS NIH HHS GM140135NIGMS NIH HHS R01 GM060518NIGMS NIH HHS R01 GM140135NIH HHS GM060518NIH HHS GM140135UM Rogel Cancer Center First and Goal AwardUniversity of Michigan
6 · The paper itself

Abstract

Alu elements are primate-specific retrotransposons that comprise ∼11% of human DNA. Alu sequences contain an internal RNA polymerase III promoter, and the resultant Alu RNA transcripts mobilize by a replicative process termed retrotransposition, which requires the long interspersed element-1 open reading frame 2-encoded protein (ORF2p). Here, we used HeLa cell-based retrotransposition assays to define a minimal Alu domain necessary for retrotransposition. We demonstrate that Alu transcripts expressed from a cytomegalovirus (CMV) RNA polymerase II promoter can efficiently undergo retrotransposition. The use of an external CMV promoter to express Alu RNA allowed us to construct separation-of-function mutations to examine the effects of large deletions within the Alu sequence on retrotransposition. Deletion mutagenesis demonstrated that a 46-nucleotide (nt) domain located at the 5' end of the Alu RNA transcript is necessary for retrotransposition. Consistent with current models, the 46-nt 5' Alu domain associates with SRP9/14 in HeLa-HA cell extracts and can promote retrotransposition in HeLa-HA cells. We propose that the 46-nt 5' Alu domain forms a discrete structure that allows for SRP9/14 binding and ribosomal association, thereby allowing the Alu poly(A) tract to compete with the L1 poly(A) tail for ORF2p RNA binding to mediate its retrotransposition.

Indexed as

Alu ElementsRetroelementsEndonucleasesHeLa CellsHumansPromoter Regions, GeneticRNA-Binding ProteinsRNA-Directed DNA PolymeraseEndonucleasesORF2 protein, humanRetroelementsRNA-Binding ProteinsRNA-Directed DNA Polymerase

Identifiers

PMID40568936
PMCPMC12199147

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.